Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2024 Earnings Call Transcript
Portfolio Pulse from
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) held its Q4 2024 earnings call on February 25, 2025. Key participants included CEO Jason Kelly and CFO Mark Dmytruk. Analysts from Morgan Stanley, Goldman, BTIG, TD Cowen, and William Blair & Company participated.

February 26, 2025 | 2:30 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Ginkgo Bioworks (NYSE:DNA) conducted its Q4 2024 earnings call, featuring insights from CEO Jason Kelly and CFO Mark Dmytruk. The call included participation from major financial analysts, indicating significant interest in the company's performance.
The earnings call is a routine event that provides insights into the company's financial performance and future outlook. The presence of analysts from major firms suggests a high level of interest, but without specific financial results or guidance, the immediate impact on stock price is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100